5351 - 5360 of 6324 Results
Title
Year
-
OPENTitle: The Avidity of Autoreactive Alpha-Synuclein Antibodies in Leucine-Rich Repeat Kinase 2 Mutation Carriers Is Not Altered Compared to Healthy Controls or Patients with Parkinson’s DiseaseJournal Name: BiomoleculesPublisher: MDPI AGVol: 13Issue #: 9Start Page: 1303End Page: 1303Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom13091303Best OA location URL: https://nbn-resolving.org/urn:nbn:de:hbz:465-20231009-105853-3Citation Count: 0
-
OPENTitle: Pedunculopontine Nucleus Dysconnectivity Correlates With Gait Impairment in Parkinson’s Disease: An Exploratory StudyJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.874692Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.874692/pdfCitation Count: 7
-
OPENTitle: Cognitive behavioural therapy for anxiety disorders in Parkinson's disease: Design of a randomised controlled trial to assess clinical effectiveness and changes in cerebral connectivityJournal Name: Journal of Psychosomatic ResearchPublisher: Elsevier BVVol: 112Issue #:Start Page: 32End Page: 39Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jpsychores.2018.04.002Best OA location URL: https://cris.maastrichtuniversity.nl/en/publications/8d94b40b-cb36-4fd4-91a7-d6c0a3ffa5adCitation Count: 16
-
OPENTitle: LRP1: a novel receptor for the transmission of pathological α-SynucleinJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-022-00582-4Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-022-00582-4Citation Count: 4
-
OPENTitle: Machine learning for predicting cognitive decline within five years in Parkinson’s disease: Comparing cognitive assessment scales with DAT SPECT and clinical biomarkersJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 19Issue #: 7Start Page: e0304355End Page: e0304355Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0304355Best OA location URL: https://doi.org/10.1371/journal.pone.0304355Citation Count: 5
-
OPENTitle: The End Is the Beginning: Parkinson’s Disease in the Light of Brain ImagingJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2017.00330Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2017.00330/pdfCitation Count: 34
-
OPENTitle: Striatal and Cortical β‐Amyloidopathy and Cognition in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 1Start Page: 111End Page: 117Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26369Best OA location URL: http://doi.org/10.1002/mds.26369Citation Count: 59
-
OPENTitle: Pregnenolone Reduces L‐Dopa‐Induced Dyskinesias in Female Parkinsonian MonkeysJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.30280Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.30280Citation Count: 0
-
OPENTitle: Local Ionic Conditions Modulate the Aggregation Propensity and Influence the Structural Polymorphism of α-SynucleinJournal Name: Journal of the American Chemical SocietyPublisher: American Chemical Society (ACS)Vol: 147Issue #: 16Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/jacs.4c13473Best OA location URL: https://doi.org/10.1021/jacs.4c13473Citation Count: 2
- Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition2019OPENTitle: Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competitionJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 132Issue #:Start Page: 104577End Page: 104577Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104577Best OA location URL: https://doi.org/10.1016/j.nbd.2019.104577Citation Count: 41